Burl Gilyard

Medtronic/medtech reporter
Medtech
Burl Gilyard is the Star Tribune's medtech reporter.

Contact

EMAIL
burl.gilyard@startribune.com
PHONE
612-673-4756

Latest from Burl Gilyard

Business

Millennium Hotel in downtown Minneapolis temporarily lays off workers for renovation

Staffers, everyone from housekeepers to bartenders, will be out of work for several months.
September 5, 2024
Minneapolis Police Public Information Officer (PIO) Sgt. Stephen McCarty described some of the circumstances surrounding a shooting and homicide early Saturday morning in a room at the Millennium Hotel, 1313 Nicollet Mall in Minneapolis. A 33-year-old male suspect was arrested after he fled to another nearby hotel.
Business

Minnesota AG Ellison warns 5,000 companies to stop selling tobacco products marketed to kids

Attorney general says the unauthorized products, some of which are candy- and fruit-flavored, violate laws and could be more attractive to children.
September 3, 2024
Health Care

Medtronic growth restrained as some business plans remain in limbo

Approvals are still needed for the Hugo robotic surgery system and Affera technology.
August 20, 2024
Business

Minnetonka-based Nautical Bowls facing lawsuits, frustrated franchisees

The company’s CEO, Snap Fitness founder Peter Taunton, was let go in June.
August 20, 2024
Health Care

HistoSonics expanding Plymouth HQ, lands $102 million in latest financing

The med-tech company uses sonic beams to destroy cancer tumors.
August 15, 2024
Business

3M health care spinoff Solventum boosts financial guidance as it repositions itself

Company announces sales of more than $2 billion in first report as a stand-alone company.
August 9, 2024
Business

Medtronic, Abbott strike diabetes devices deal, giving patients more options

Analysts see the partnership as positive for Medtronic, which has had some stumbles in its diabetes division.
August 8, 2024
ALLISON SCHOLL, 16, (left) and ELEANOR HEDLUND, 17, pose for a photo at the Park Nicollet International Diabetes Center while holding their new Medtronic MiniMed 670G insulin pumps. Scholl and Hedlund are among the first type 1 diabetes patients in the nation to receive the device, which is the only insulin pump approved in the U.S. to predict how a patientís blood-glucose levels will change over time and then adjust insulin doses in response. ] Joe Carlson - Star Tribune Minneapolis, MN
Business

Minnesota health care startups see investment rebound after lackluster 2023

Second-quarter venture capital investments are up nearly 85% compared to last year, a recent low for funding of med-tech companies in the U.S.
August 5, 2024
Health Care

HistoSonics expanding Plymouth HQ, lands $102 million in latest financing

The med-tech company uses sonic beams to destroy cancer tumors.
August 15, 2024
Business

3M health care spinoff Solventum boosts financial guidance as it repositions itself

Company announces sales of more than $2 billion in first report as a stand-alone company.
August 9, 2024
Business

Medtronic, Abbott strike diabetes devices deal, giving patients more options

Analysts see the partnership as positive for Medtronic, which has had some stumbles in its diabetes division.
August 8, 2024
ALLISON SCHOLL, 16, (left) and ELEANOR HEDLUND, 17, pose for a photo at the Park Nicollet International Diabetes Center while holding their new Medtronic MiniMed 670G insulin pumps. Scholl and Hedlund are among the first type 1 diabetes patients in the nation to receive the device, which is the only insulin pump approved in the U.S. to predict how a patientís blood-glucose levels will change over time and then adjust insulin doses in response. ] Joe Carlson - Star Tribune Minneapolis, MN
Business

Minnesota health care startups see investment rebound after lackluster 2023

Second-quarter venture capital investments are up nearly 85% compared to last year, a recent low for funding of med-tech companies in the U.S.
August 5, 2024
Back to Top